Treating to Target Confers Enhanced LDL Cholesterol Reductions Compared to a Fire and Forget Approach in Fontaine I/II Peripheral Arterial Disease
Main Authors: | Penelope Sucharitkul, Nawaz Safdar, Kinshuk Jain, Benoit Jauniaux, Ryan Laloo, Keely Jones, Marc Aaron Bailey, David Julian Ashbridge Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | EJVES Vascular Forum |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666688X21001180 |
Similar Items
-
Strong Clinician Preference of Aspirin Over Clopidogrel in the Antithrombotic Management of Mono and Polyvascular PAD
by: Kinshuk Jain, et al.
Published: (2022-01-01) -
Fontaines de Paris
by: Gustave Fulgence -
Fontaine, Naomi. Shuni
by: Julien Defraeye
Published: (2019-11-01) -
Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwayss⃞
by: Ming-Dong Wang, et al.
Published: (2007-03-01) -
Quo vadis, LDL cholesterol?
by: Cobos Andrés, et al.
Published: (2023-05-01)